Abstract -The right ventricle has frequently been described as the forgotten ventricle in the circulation. However, its importance both in acquired and congenital heart disease is now unquestioned. This recognition has led to improved risk stratification and development of algorithms for intervention, which incorporate measurements of right ventricular function as key components of the assessment of many conditions. Indeed, such has been the emphasis on characterizing right ventricular dysfunction; the contribution of left ventricular dysfunction to the outcomes of diseases traditionally thought of as right sided has perhaps been underappreciated. In this review, we remind ourselves of the biventricular nature of almost all cardiovascular diseases and, in particular, how the left ventricle can both be a culprit in causation of, and a potential therapeutic target for, late morbidity and mortality in congenital heart disease. (Circ Cardiovasc Imaging. 2018;11:e007410.
T he left ventricle (LV) has historically received more attention in both congenital and acquired heart disease, pedestaled as the mainstay of normal hemodynamics. As a result, the right ventricle (RV) has often been labeled the forgotten ventricle. 1 During the past few decades, there has been increasing recognition of the pivotal role of dysfunction of the RV in determining functional performance and outcomes in many congenital and acquired heart diseases. [1] [2] [3] Indeed, it is easy to argue that a focus on RV performance has led to fundamental changes in our understanding of cardiovascular physiology, the archetypal embodiment of that hypothesis being tetralogy of Fallot (TOF). 4 In a relatively short period of time, we have moved from considering pulmonary incompetence and secondary RV dysfunction as innocent bystanders in the late follow-up after tetralogy repair to them now being considered the key drivers of adverse outcomes and their accurate assessment fundamental to decision-making. 5, 6 This shift in balance, in some regards, has led to an underappreciation of the LV in right-sided congenital heart disease (CHD). However, during the past decade, emerging data have suggested that the LV may be at least as important as the RV in determining outcomes in some patients. Consequently, the LV should not be considered an innocent bystander and cannot be forgotten in efforts to characterize cardiovascular performance and risk factors for adverse outcomes in diseases traditionally confined to the right side of the heart. In this review, we will consider the importance of, and mechanisms for, LV dysfunction in right-sided CHD in an effort to optimize the evaluation and management of this heterogeneous population of patients.
LV Myofibril Arrangement, Mechanics, and Ventricular Interactions Normal Architecture and Mechanics
During the past decade, the once-accepted helical ventricular myocardial band model of biventricular architecture, proposed by Torrent-Guasp, has been undermined. 7 Although important in concept, emphasizing the exquisite anatomic and functional interdependence between the 2 ventricles, the normal myocardial arrangement of the ventricles has been demystified. It is now known to be comprised of a complex interweaving mesh of endlessly looping ventricular myocytes arranged in helical fashion and aggregated within a supporting fibrous matrix. 7, 8 The myocardial fibers in the LV, or more accurately referred to as aggregated cardiomyocytes, are oriented from subendocardial to subepicardial in a longitudinal, circumferential, and oblique orientation together forming the prolate ellipsoid shape, with the middle layer occupying approximately half of the ventricular wall thickness. These fibers predominantly account for circumferential and radial LV contraction. Indeed, most computational models assessing LV mechanics have depicted the LV myocardial architecture as having 2 helical fiber orientations: the subendocardium arranged in a righthanded helical geometry and the subepicardium arranged in a left-handed helical geometry. These oblique fiber orientations allow for the achievement of a normal ejection fraction (EF). Whereas if fibers were orientated in a purely longitudinal or circumferential fashion, the ventricle would only be able to achieve an EF of ≈15% and 28%, respectively. 9 Importantly, the superficial layer comprising the subepicardium is shared Left Ventricle in Right-Sided CHD between both ventricles with, for example, chains of aggregated cardiomyocytes extending from the RV outflow tract, across the LV anterior wall, to the LV apex ( Figure 1 ). 7, 8, 10, 11 Consequently, the LV and RV cannot be considered singularly, and it becomes obvious that events on one side of the heart necessarily will affect the contralateral side. Mechanistically, this is amply demonstrated by the exquisite experiments by Damiano et al. 12 They showed, in experiments where the 2 ventricles were electrically isolated but their mechanical contiguity was maintained intact, that LV contraction alone was responsible for ≤60% of stroke volume from the normal RV. Conversely, acute right heart dilatation in the otherwise normal heart leads to reduced LV contractility independent of pericardial constraint. 13 So intuitively, with a shared septum and shared myocardial fibers, not to mention a communal pericardial space, the 2 ventricles are immutably wedded, for better or worse. 14 With the advent of deformation assessment in both echocardiography and cardiac magnetic resonance imaging, these interrelationships can now be examined in our patients. What had been considered strictly a research tool has broken into the clinical arena, with well-established normative adult and pediatric deformation values in both 2 dimensions and now 3 dimensions. [15] [16] [17] [18] The combined longitudinal, circumferential, and radial strain result in the normal LV wall shortening, thickening, and rotation along the long axis of the ventricle. The opposing rotation of the apex and base of the LV in systole, counterclockwise versus clockwise, respectively, when viewed from the apex, creates the normal LV twist or torsion that defines the apex-to-base gradient in this rotation along this same long axis. 11 To add more complexity, however, there is a clear shift in deformational mechanics with maturation, with predominate basal function in infancy and childhood, progressing toward predominate apical function thereafter.
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LV Adaptation to Abnormal RV Architecture and Mechanics
These proposed concepts of ventricular mechanics and ventricular-ventricular interaction have been evident in the investigations of patients with right-sided CHD, from the level of the individual myofibril arrangement to their congruent interactions. The myofibril arrangement in both ventricles has been shown to change orientation to adapt to physiological aberrations and also adapt with regional hypertrophy. 14, 19, 20 Analysis of the RV of pathological specimens with both unrepaired and repaired TOF has reported a hypertrophied circumferential layer, as well as a change in fiber orientation, the former of which is consistent with the observed increase in circumferential strain, and a pressure-volume loop, which mirrors that of the normal LV, with increased systolic pressure generation and distinguishable isovolumetric periods. 14, 19, 21 The LV similarly demonstrates more oblique subepicardial fibers in TOF when compared with the normal heart, confirming that from the outset, it is not just an innocent bystander. 19 Animal models assessing various forms of direct hemodynamic burden on the LV demonstrated increased longitudinal oriented fibers in models of aortic stenosis, with retention in the composition of normal fiber orientation in the volume-loaded LV. 20 These findings suggest that, similar to the pressure-loaded RV, although the pressure-loaded LV may result in selected hypertrophy of specific layers, hemodynamic derangement of the RV can additionally affect the fiber orientation of the LV through ventricular-ventricular interactions.
Just as deformation imaging has provided insight into normal ventricular mechanics, it has also allowed better understanding of altered mechanics, such as those encountered in right-sided CHD. However, the data regarding LV responses lack consistency. This is likely because studies include heterogeneous cohorts of varying ages, with various forms and degrees of right heart pathology and dysfunction. However, Figure 1 . The general components of ventricular-ventricular interactions are listed. Left, The gross anatomic structure of the subepicardial aggregated cardiomyocytes, which are shared between the ventricles (provided by Damian Sanchez-Quintana). Right, A magnetic resonance diffusion tensor image (DTI) of a normal heart, displaying a 3-dimensional depiction of the aggregated cardiomyoctes (provided by Peter Agger). As indicated by the curved double-headed arrows, a clear continuation of chains of cardiomyocytes can be found from the right ventricular (RV) outflow tract to the left ventricular (LV) free wall. This finding is evident in both the anatomic and DTI panels. The color coding in the DTI panel is an arbitrary directional color coding that only serves to increase the 3-dimensional understanding of the figure and is not meant to convey any anatomic or physiological message. Left Ventricle in Right-Sided CHD what is clear is that in almost all conditions that have been examined, LV mechanics and ventricular-ventricular interactions are adversely affected in both the pressure-loaded and volume-loaded RVs, independent of electromechanical interactions. [22] [23] [24] [25] [26] Consequently, these responses cannot be considered generically, and each condition will need to be examined as a distinct entity, and even within a particular patient group, the differential effect of variable residual load will likely affect LV function in different ways. We will illustrate these concepts with a review of the available data, and discussion of new concepts, in some commonly encountered situations.
Tetralogy of Fallot
The linear relationship that exists between RV EF and LV EF in the late follow-up of patients with TOF has been known for decades, but the underlying mechanisms for this relationship have been less clear. Both mechanical and electromechanical aberrations have been implicated as possible culprits. Prolonged RV contraction in the obstructed RV outflow tract of some patients with repaired TOF may impair LV diastolic filling because of persistent RV systole interfering with normal LV restoring forces and resulting septal shift impinging on the LV cavity in early diastole. 27 In volume-loaded RVs, abnormal diastolic excursion of the interventricular septum has been demonstrated to correlate with increased pulmonary regurgitation, RV volumes, and QRS duration, as well as decreased RV and LV EF, suggesting both abnormal mechanical and electromechanical interactions. 28 In addition, abnormal diastolic septal position in the setting of RV restrictive physiology, reported to be present in over one half of adolescents with repaired TOF, has been linked to impaired late diastolic LV filling. 29 Recent attempts to address these adverse late effects, such as an intentional surgical strategy to perform minimal subvalvar resection with pulmonary valve preservation to prevent the detrimental effects of long-term pulmonary regurgitation, 30 have been shown to result in improved RV deformation with more robust RV-LV interactions and less interventricular dyssynchrony. However, this may be at the expense of reduced LV longitudinal deformation and LV intraventricular dyssynchrony, 31 which itself may be a predictor of adverse outcomes. 32 Indeed, several studies have demonstrated decreased LV circumferential or radial deformation, 22, 24, 33, 34 although some also report decreased LV longitudinal deformation, 25, 26, 31, 32, 35, 36 both in the setting of RV dilation 22 and obstruction. 31 In those with preserved LV EF, the LV basal region tends to be affected early on, with a compensatory increase in LV apical rotation. 24, 25 This abnormal (counterclockwise) rotation of the LV base has been identified as an early sign of both LV systolic and diastolic dysfunction and has been correlated with preceding decreased RV apical longitudinal deformation, RV dilation, and prolonged QRS duration, with abnormalities of deformation having the strongest correlation. 24 The importance of the RV apex in the adaptive response of the LV-to-RV volume overload, with deterioration of RV apical strain leading to deterioration of LV systolic function, is increasingly recognized as an early maladaptive phenomenon, which is often detected in the first postoperative decade. This may be because the RV apex is more affected by wall stress because it is thinner than the other segments, resulting in a dilated and more rounded apical shape, or because of the shared interventricular fibers, which spiral together toward the apex 8, 24, 36, 37 ; however, this is unclear. Conversely, the curvature of the apex is higher relative to the base, and following Laplace's equation, wall stress is expected to be relatively lower. The resulting decrease in LV longitudinal strain may herald the development of depressed LV EF as LV free wall, 22, 24, 26 and basal LV function also becomes abnormal. 28, 36 Most of the clinical data have been obtained in patients with a predominantly volume-loaded RV, as a consequence of pulmonary regurgitation, and there is a clear correlation between the degree of RV dilation and global LV systolic dysfunction. Furthermore, pulmonary valve replacement has been shown to lead to improved LV EF, with the greatest response seen in those with the most significant preoperative LV dysfunction, further supporting a causal relationship. 38 However, although there is an extensive literature regarding preoperative risk stratification based on postoperative reversed mechanical and electrical remodeling for the RV, less is known in regard to LV recovery. Nonetheless, in a cohort of young adults with preserved preoperative biventricular systolic function, who underwent surgical pulmonary valve replacement at a relatively lower RV volumetric threshold (mean indexed RV end-diastolic volume of 154 mL/m 2 ), all patients had normal values of all LV deformational parameters postoperatively. 39 Clearly, more data are required in this regard because both preoperative and postoperative LV dysfunction are important potential predictors of outcomes after successful pulmonary valve replacement.
As discussed earlier, given all of the emphasis that has been placed on understanding RV pathophysiology in the late follow-up of repaired TOF, LV dysfunction is emerging as a highly important predictor of outcomes, both late after repair and after pulmonary valve replacement. For example, it is interesting to note that of all the risk factors assessed, it was a raised LV enddiastolic pressure (LVEDP; >12 mm Hg) that was the strongest predictor of appropriate shock in patients with an implantable cardioverter defibrillator ( Figure 2 ). 40 Although there is some relationship between RV volume and LV end-diastolic pressure, 41 the relationship is loose and somewhat idiosyncratic. This suggests that although direct mechanical interactions may be a partial explanation, other factors may be at play. One such factor may be LV fibrosis. We and others 42, 43 have shown in experimental preparations, isolated hemodynamic load on the RV can lead not only to maladaptive remodeling of the RV (as might be expected) but also within the LV-manifest as LV scarring at the septal hinge points and more diffusely as interstitial fibrosis throughout the LV free wall. 44 This is driven by upregulation of profibrotic pathways (transforming growth factor beta, endothelins, etc) within the LV myocardium.
With our improved ability to image fibrosis in patients, similar LV scarring and fibrosis is being described late after TOF repair. As expected, late gadolinium enhancement (LGE)-an indicator of discrete replacement fibrosis-is typically observed in the RV outflow tract and surrounding the ventricular septal defect patch in patients with repaired TOF, often extending to the anterior RV free wall. [45] [46] [47] [48] [49] However, the majority of these patients additionally have LGE located in the septal insertion points between both ventricles, which has been linked to abnormal diastolic interventricular septal excursion and LV systolic dysfunction. 28, 45, 49 Similar findings, which may mediate adverse interventricular interactions, have been demonstrated in patients with pulmonary hypertension. 50 Furthermore, Babu-Narayan et al 45 reported LV LGE (predominantly at the LV apex, at the septal insertion points, but also in the free wall) in >50% of the adult tetralogy patients studied, its presence being associated with adverse outcomes. 45, 49, 51 Although speculative, LV LGE at the apex is consistent with direct trauma from LV venting at the time of surgery, whereas fibrosis at the septal insertion points suggests a role of adverse mechanical coupling and is consistent with animal data. 44 The origin of free wall scarring is more compatible with ischemic myocardial injury, but the mechanism for ischemia is not clear. 28, 45, 49 However, in another study, of a younger cohort of patients with repaired TOF who did not have placement of an LV vent at the time of initial repair, LV
LGE was not present. Whether this was solely related to the difference in age, or in combination with a difference in surgical technique, is unclear. 47 A significant contribution of the former is suggested by a histopathology study that correlated the percentage of LV fibrosis positively with the age of death but also correlated negatively with the age of initial repair. 51 Although discrete replacement fibrosis is best identified by LGE, 46 extracellular volume (ECV) assessment by T1 mapping-a newer strategy that assesses the ratio of interstitial volume to the total myocardial volume-is now the most widely used imaging strategy for interstitial fibrosis. 46, 52 Chen et al 48 measured the LV ECV value in 84 young adult patients with repaired TOF (mean age of 23 years), reporting elevated LV ECV in 13% of patients, which correlated independently with elevated RV ECV and RV dilation, which supports adverse mechanical coupling as a potential cause. They also demonstrated an association between LV ECV and the incidence of arrhythmias, with no association between elevated ECV values and pulmonary stenosis or mixed disease suggesting a greater adverse response to volume overload. The correlation between decreasing mass-to-volume ratio and increasing ECV suggests a maladaptive process involving myocyte atrophy and diffuse fibrosis. 48 Broberg et al 53 similarly assessed LV ECV in patients with repaired TOF albeit in a much older cohort (mean age of 40 years). They reported an even higher percentage of patients with elevated LV ECV (29%), despite utilizing a higher upper limit of normal, perhaps suggesting an increased incidence of myocardial fibrosis with age. LV ECV in Broberg study correlated with age at repair, QRS duration, a, d, g, and j) , PAB (b, e, h, and k), and PAB with Los (c, f, i, and l) animals. B, Quantitative collagen volume fractions in various groups were analyzed by an image-analyzing system (n=6 for the sham group, n=8 for the PAB group, and n=6 for the PAB 1 Los group). Reprinted from Friedberg et al 44 with permission. Copyright ©2013, the American Thoracic Society. Left Ventricle in Right-Sided CHD exercise capacity as determined by a 6-minute walk distance, B-type brain natriuretic peptide, and biatrial volumes. 53 Similarly, Riesenkampff et al 54 reported a correlation between markers of diffuse myocardial fibrosis after TOF repair with longer cardiopulmonary bypass and aortic cross clamp times at surgery, biventricular enlargement, and reduced exercise tolerance. Interestingly, there was no correlation with systolic function in either study, highlighting that myocardial fibrosis often precedes overt systolic ventricular dysfunction. 53, 54 Nonetheless, in another study, increased circulating proinflammatory markers in the blood were associated with worse RV function in tetralogy patients, suggesting these biomarkers may also help in predicting adverse outcomes. 55 These fascinating data raise more questions than they can currently answer. Although ECV and interstitial fibrosis are increasingly recognized as markers of adverse outcomes in a variety of diseases, 56 it remains to be seen whether, for example, increased interstitial fibrosis is an explanation for the raised LVEDP seen in some patients, as we discussed earlier as a risk factor for adverse outcomes. Even more intriguing is the potential for therapy to reverse interstitial fibrosis in some disease states. In experimental models, the LV fibrosis that occurs with RV hemodynamic load can be completely abrogated using generic pharmacological blockade of the transforming growth factor beta pathway and endothelin blockers, and many other specific inhibitors of myocardial fibrosis signaling are being developed by pharma. 44, [56] [57] [58] [59] We, for example, have shown that the LV fibrosis that occurs in response to isolated RV pressure load can be completely normalized by angiotensin receptor blockade in an animal model (Figure 3) . 44 Although the data are far too immature to suggest therapeutic trials, this is an exciting area of potential future research endeavor.
Although TOF, and its variants, represents numerically the largest and the most extensively studied population of patients, other right heart diseases have a significant biventricular component to their pathophysiology, the understanding of which is important to ultimately improving their outcomes.
Ebstein's Anomaly
The biventricular nature of Ebstein's anomaly is exemplified by its association with LV noncompaction 60 ; however, even in the absence of overt structural abnormalities, LV dysfunction is commonly detectable. For example, a study of adults with Ebstein's anomaly reported depressed LV deformation values, specifically in the base and midventricle, in all Ebstein patients. The degree of LV dysfunction was the greatest in those with the most marked RV dilation, and frank LV systolic dysfunction, as measured by reduced LV EF, was seen in 50%. The greater dilation at the RV base seen in these patients, related to their atrialized RV, suggests a different mechanism for progressive LV dysfunction, compared with that seen with repaired TOF (where, as discussed, apical RV dilation is commonly the earliest driver of abnormal LV deformation). 61 This is supported by data obtained by cardiac magnetic resonance 3-dimensional virtual modeling, which shows that RV basal dilation is associated with basal LV narrowing and elongation of the LV cavity. When present in these adult patients, LV systolic dysfunction was associated with marked interventricular septal dyskinesis. Interestingly, unlike in tetralogy, there was a relatively poor correlation between RV EF and LV EF, with better correlation between LV EF and parameters of RV long-axis shape and function. This goes along with a different mechanism of ventricular interaction, imposed by the different anatomic substrate, and physiological consequences of RV loading from tricuspid incompetence rather than the pulmonary incompetence that is typical in TOF. This finding suggests that RV longitudinal function in Ebstein patients drives interdependence with LV systolic function, perhaps because shared circumferential fibers are disrupted by the abnormally positioned tricuspid valve. 62 Although the lack of correlation between RV EF and LV EF in Ebstein's anomaly is not a novel finding, 63, 64 this alternative explanation for apparent septal dyskinesis and contributing factors toward depressed LV systolic function shed light on potential ventricular-ventricular interactions, beyond simple septal shift, and may be important when considering surgical strategy in this entity.
Despite the difference in underlying mechanism, just as in tetralogy, there is a similar impact of improved RV hemodynamics on postoperative LV remodeling (again supporting a causal relationship), and, furthermore, poor preoperative LV function is a risk factor for a poor outcome of surgical intervention in Ebstein patients. Indeed, in a study of almost 500 patients reported from the Mayo clinic, tricuspid repair was associated with improved LV function postoperatively in the majority; however, those with poor preoperative LV function had worse early and long-term survival. 65 The mechanisms for adverse long-term outcomes, even when LV global function is only relatively impaired, is not known, but similar to emerging data in TOF, LV myocardial fibrosis has been identified both in the LV free wall and interventricular septum of patients with Ebstein's anomaly and has been suggested as a contributor to abnormal LV diastolic function in these patients. 66 Although it has been suggested that LV fibrosis results from arterial oxygen desaturation or long-term RV volume overload, 63 ,67 a truly causal relationship has not been defined. Once again, more data are required before robust recommendations can be made on preoperative management, or perioperative risk stratification according to the degree of LV dysfunction, but this is obviously an area of investigation that is likely to be significantly impactful.
Congenitally Corrected Transposition of the Great Arteries
Severe tricuspid valve regurgitation leading to systemic RV failure in congenitally corrected transposition of the great arteries (CC-TGA) is an extremely challenging situation. Traditional heart failure therapies have summarily failed to improve RV systolic function, 68 and in the setting of an RV EF of <40%, outcomes after tricuspid valve repair or replacement are poor with an estimated late mortality or transplant at 10 years after surgery to be ≈40%. 69 Consequently, many would advocate for heart transplantation under these circumstances. Alternative strategies to potentially harness beneficial RV-LV interactions that might delay the need for transplantation, or even reverse the process of progressive tricuspid regurgitation-induced RV failure, may, therefore, have a role. These strategies recognize the impact of the subpulmonic LV on that of the systemic RV, as well as the ability of the subpulmonic LV to be prepared to sustain the systemic circulation after anatomic repair. The important discussion on timing of potential surgical repair, which itself is largely dependent on associated cardiac lesions and resulting symptoms, as well as the general decision between physiological versus anatomic repair, or if surgical intervention is even necessary in the occurrence of CC-TGA with a ventricular septal defect and a beneficial degree of subpulmonary stenosis with relatively balanced Qp:Qs, is beyond the scope of this review. [70] [71] [72] [73] What is relevant is the common occurrence of both tricuspid regurgitation and RV failure-an important determinant of outcomes 71, 74, 75 which is largely dependent on interventricular mechanics and the resulting septal shift in addition to the common occurrence of anatomic tricuspid valve abnormalities. 75, 76 In unrepaired and physiologically repaired CC-TGA, tricuspid regurgitation occurs in over half of all patients. 70 This is thought to be related to increasing RV pressures with subsequent cavity dilation, causing the interventricular septum to shift toward the LV pulling the septal attachment of the tricuspid valve along with it. 76, 77 Similarly, in the physiologically repaired patient with stenosis of an LV to pulmonary artery (PA) conduit, overly aggressive relief of this obstruction can have detrimental effects to the septal position with resulting tricuspid regurgitation and RV failure. 78, 79 This important concept related to septal shift underlies one of the indications for placing a PA band to manipulate the septal position, as a therapeutic strategy to improve and even prevent significant tricuspid regurgitation. More commonly, however, in a patient with CC-TGA devoid of a ventricular septal defect, a PA band is placed to increase the afterload to the deconditioned LV and prepare it to become the systemic ventricle before anatomic repair. 80 It has been suggested that both older age (>12-16 years) and the need for LV training may predict worse outcomes, including the late postoperative occurrence of LV systolic dysfunction, suggesting that both the duration and magnitude of subsystemic pressures seen before anatomic repair dictates the ability to properly prepare. 80, 81 Although statistically, and perhaps physiologically, the older LV is undoubtedly more difficult to train, and its ultimate performance may be limited (just as with skeletal muscle training), the dogma that it is untrainable is not supported by data. Indeed, successful LV training has been reported in young adults, and the studies suggesting that age alone may be a mitigating factor against attempted retraining show that it is preexisting or induced LV dysfunction that predicts outcome and that if LV dysfunction is avoided, then age is not a risk factor. 77 The key, therefore, may be to be smarter about the way we train the subpulmonary LV, with particular precision being required in the older the patient. This is important because for those older patients with unoperated CC-TGA, or physiologically repaired CC-TGA with severe tricuspid regurgitation and RV dysfunction (RV EF, <40%), the outcomes for tricuspid valve replacement are poor. 69 A successful PA band procedure(s), conserving LV function and inducing septal shift, may ultimately be a better alternative-perhaps even a destination therapy in and of itself. 82 The key is to avoid LV damage during the banding procedure because LV EF and LV free wall longitudinal deformation have been shown to decrease after PA banding, likely related to increased afterload with further decremental decrease in LV systolic function after subsequent anatomic repair. 83 We think, and have emerging evidence, that this can be achieved even in aged ventricles, with careful hemodynamic assessment. Figure 4 shows pressure-volume curves obtained using intraoperative conductance catheter recordings in the subpulmonary LV during PA banding. As can be seen, there is a period of linear pressure and volume increase in response to increasing afterload (akin to an elastance curve that is usually obtained using preload reduction) that occurs during the early part of band tightening. Banding to an LV pressure in this adaptive phase is likely to be well tolerated because it is part of the normal operating curve of a functional ventricle. Because the band is tightened, the relationship becomes curvilinear with a decreasing slope (elastance, or contractility, is reducing), and the slope ultimately becomes negative (ie, developed pressure is falling in the presence of continued LV dilation), and the ventricle at this stage is clearly failing. It is interesting to note that banding to an identical pressure on the adaptive portion of the slope as on the maladaptive or failing part of the curve will likely lead to different consequences for the LV, and the patient, and so, using LV pressure alone as a guide to the adequacy of banding is flawed. Conversely, the use of pressure-volume curves to guide therapy has a much better chance of avoiding LV dysfunction. We have been using this technology to guide PA banding in older teenagers and adults up to the age of 56 years with CC-TGA. Importantly, patients may require several banding procedures to achieve optimal hemodynamics without overt LV dysfunction. The first band, in particular, may induce LV failure at a pressure increment above baseline of just a few mm Hg (often substantially below half-systemic pressure). Nonetheless, when banded within the adaptive portion of the curve (empirically to two thirds of the pressure that is associated with flattening of the pressure-volume curve), no overt LV dysfunction is measurable echocardiographically, and the patient should not require postoperative inotropes to maintain cardiac output. Figure 5 shows the prebanding magnetic resonance imaging for a 23-year-old patient and the subsequent images after 2 banding procedures (Movies I and II in the Data Supplement). Note how the degree of tricuspid regurgitation has reduced from severe to mild, with secondary improvement in subaortic RV volumes and systolic function, and normalization of left This anecdotal experience clearly needs confirmation in more completely reported datasets, but this experience serves as a reminder that the LV may not only be an important contributor to the pathophysiology of CHD but may also be a therapeutic target, even when it is not the primary cause of failure.
LV in the Fontan Circulation
It is paradox to discuss the forgotten LV, when in this case, it may be the only functional ventricle. However, we feel the role of the functional single ventricle, be it of right or left morphology, has been underappreciated in the setting of the failing Fontan. This is not to minimize the importance of the Fontan pathways, or the associated pulmonary and systemic vascular beds in the Fontan circulation, but, for many, Fontan failure will occur with no overt changes in any of these aspects. Furthermore, although it is unsurprising that when there is moderate or severe systemic ventricular systolic dysfunction, Fontan outcomes are poor, 84 the progressive functional decline toward overt Fontan failure (ie, protein losing enteropathy, plastic bronchitis) frequently occurs in the presence of normal ventricular systolic function and a normal ventricular end-diastolic pressure. [85] [86] [87] Indeed, the systemic ventricle after the Fontan operation, whether morphologically left or right, appears to be hypercontractile, and well coupled to increased vascular elastance, 88 reflective of the increased systemic vascular resistance 89 and decreased arterial compliance evident in these patients. 90 This physiological response was further confirmed in Fontan patients with tissue Dopplerderived assessment of the force-frequency relationship. This indirect measurement of contractile reserve demonstrated supra normal values, both in the single RV and LV. 91 It would be unlikely that afterload reduction would be beneficial under these circumstances, and this is born out in the available data. In a randomized, placebo-controlled crossover study of enalapril, there was no demonstrable benefit of drug, in terms of echocardiographic or functional indices, and exercise-induced increase in cardiac output was blunted while taking enalapril, suggesting the potential for harm. 92 Consequently, although it would be an exaggeration to say that the LV has been forgotten as a culprit in Fontan decline, there can be no doubt that attention has concentrated on the pulmonary vascular bed and right heart as potential therapeutic targets. Although not entirely irrational (some patients will respond well to Fontan revision, others will show marked improvement in functional capacity with pulmonary vasodilator therapy), there is no unifying pathophysiologic substrate that explains Fontan failure for the majority of patients.
However, could it be that Fontan failure is a manifestation of heart failure with preserved EF, albeit with much more covert diastolic abnormalities than often seen in the aging population with structurally normal hearts? It has long been known that the large change in mass-volume ratio that occurs with conversion from the parallel palliated circulation to the series circulation after the Fontan procedure is associated with profound abnormalities of diastolic relaxation. This is manifest as reduced early diastolic flow velocity across the inflow valves, prolongation of isovolumic relaxation time and τ, etc. 93 These abnormalities of relaxation appear to be a consequence of incoordinate wall motion 94 with segments of the ventricular wall demonstrating postsystolic shortening, leading to disruption of early rapid filling ( Figure 6 ). Such abnormalities have been associated with slower early postoperative recovery 95 and persist in the long-term. 96 The acquired hypertrophy of ventricular preload reduction also may persist, 97, 98 and an increased mass-volume ratio and reduced E-wave filling velocities were prominent findings of the PHN cross-sectional study (Pediatric Heart Network) performed in patients on average ≈8.5 years after Fontan completion. 86 However, there are additional, more subtle, diastolic abnormalities that begin to emerge as follow-up increases. In 1 longitudinal study, incoordinate relaxation persisted 8 years after Fontan, but at follow-up, there was evidence of worsening LV compliance, with more rapid E-wave deceleration and shortening of isovolumic relaxation time. 96 Going along with this, the data from the aforementioned PHN study show a significant number of patients with concomitant increase in their E/E′ ratio, suggesting a trend toward increasing LVEDP. 86 Reduced ventricular filling in early diastole with worsening ventricular compliance in late diastole would be a potent adverse combination in the passive circulation of Fontan patients, but as mentioned previously, changes in LVEDP are an inconsistent feature of the failing Fontan circulation. Again, as with our evolving understanding of the physiology of CC-TGA, we may have to be more detailed in our assessment of these complex patients. Unlike in the biventricular circulation, LV preload reduction because of right heart failure may mask any rise in LVEDP, despite worsening ventricular compliance. Indeed, when preload challenged, many of these ventricles demonstrate a pathological increase in LVEDP when stressed with volume infusion during cardiac catheterization, 99 for example. Early data from cardiac magnetic resonance are intriguing in this regard. Replacement fibrosis as measured by LGE was present in over one quarter of young adult Fontan patients, correlating with lower systolic function, increased end-diastolic volume, increased ventricular mass, the presence of regional wall motion abnormalities, and a higher incidence of nonsustained ventricular tachycardia.
100 T1 relaxometry to measure extracellular volume as a surrogate of interstitial ventricular fibrosis was significantly abnormal in Fontan patients compared with healthy controls, 101 and in another study, circulating profibrotic markers were markedly increased in the plasma of single-ventricle patients compared with controls. 102 If the Fontan circulation is indeed forced into failure via a heart failure with preserved EF-like mechanism, then it is somewhat depressing in terms of therapeutic options. To our advantage is the fact that these patients are under our care from an early age and could be treated with drugs of possible benefit in heart failure with preserved EF (ie, angiotensin receptor blockers and spironolactone), or other emerging antifibrotic therapies, for years or decades before clinical deterioration. As previously stated, however, afterload reduction has failed to demonstrate improvements and may even impart harm. 92 Conversely, such studies would be exceptionally difficult to justify and perform, given the large number of patients who would need to be recruited and the required duration of follow-up. Nonetheless, this is an important area of future research and improved understanding because we have to deal with an ever-increasing burden of Fontan failure and its multiorgan consequences in our patients.
Conclusions
Although the forgotten RV is now truly a thing of the past, and its importance is recognized as pivotal to outcomes in acquired and CHD, we now must not forget the potential influence of the LV on prognosis and outcomes in patients sometimes considered to have exclusively right heart diseases. Through a complex interplay of both mechanical and electromechanical coupling, as well as neurohormonal interactions that might induce myocardial fibrogenesis, RV impairment begets LV impairment. The pathophysiology of these interactions is yet to be fully determined; however, evidence in most forms of right-sided CHD emphasizes the importance of the LV, with both interventricular septal position and shared myocardial fibers in directing adverse mechanical coupling, with more recent evidence suggesting identifying and treating LV fibrosis as a viable therapeutic target. What is clear is these interactions mandate that we do not forget either ventricle when assessing acquired and CHDs; their function is inextricably linked, and the pathophysiology of their outcome cannot be wholly understood using a singular approach.
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